Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;397(5):3093-3109.
doi: 10.1007/s00210-023-02791-0. Epub 2023 Oct 25.

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

Affiliations

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

María Inés Ragone et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 May.

Abstract

Nebivolol could prevent dysfunction in patients suffering myocardial ischemia. However, influence of hyperthyroidism is not known. Consequences and mechanisms of nebivolol treatment were investigated in isolated hearts from euthyroid (EuT) and hyperthyroid (HpT) rats. Rats were orally treated during 1 week with 20 mg/kg/day nebivolol (O-Neb), 30 mg/kg/day atenolol (O-Ate), or not treated (C). Isolated perfused hearts were exposed to global ischemia and reperfusion (I/R) inside a flow calorimeter. Left diastolic ventricular pressure, developed contractile pressure (P), and total heat rate (Ht) were continuously measured, while infarct size was measured after 2-h R. EuT-C and HpT-C hearts developed similarly low post-ischemic contractile recovery and economy (P/Ht). Nebivolol totally prevented dysfunction and reduced infarction size in EuT hearts, but partially improved recovery in HpT rat hearts. Contrarily, oral atenolol totally prevented dysfunction in HpT hearts but partially in EuT hearts. Nebivolol effects were reversed by perfusing L-NAME in both conditions, but partially reduced by aminoguanidine in HpT. However, L-NAME increased P and P/Ht recoveries in EuT-C and HpT-C rat hearts, as well as melatonin. Oral nebivolol prevented post-ischemic dysfunction and infarction in EuT hearts due to adrenergic β1 blockade and activation of iNOS and/or eNOS, but the effect was attenuated in HpT hearts by excessive iNOS-dependent nitrosative pathways.

Keywords: Atenolol; Cardioprotection; Hyperthyroidism; Melatonin; NO-synthases; Nebivolol.

PubMed Disclaimer

Similar articles

References

    1. Al Habeeb W, Mrabeti S, Abdelsalam AAI (2022) Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc Drugs Ther 36(5):959–971. https://doi.org/10.1007/s10557-021-07205-y - DOI
    1. Ambrosio G, Flather MD, Böhm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJS (2011) β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3):209–214. https://doi.org/10.1136/hrt.2010.207365 - DOI - PubMed
    1. Audigane L, Persello A, Piriou N, Ferron M, Trochu J-N, Lauzier B, Gauthier C, Rozec B (2021) Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3-adrenoceptor remodelling. Clin Exp Pharmacol Physiol 48(7):1007–1015. https://doi.org/10.1111/1440-1681.13447 - DOI - PubMed
    1. Bermudez-Gonzalez JL, Sanchez-Quintero D, Proaño-Bernal L, Santana-Apreza R, Jimenez-Chavarria MA, Luna-Alvarez-Amezquita JA, Straface JI, Perez-Partida AM, Berarducci J, Armenta-Moreno JI, Garza-Cruz KJ, Espinola-Zavaleta N, Alexanderson-Rosas E (2022) Role of the antioxidant activity of melatonin in myocardial ischemia-reperfusion injury. Antioxidants 11(4):627–632. https://doi.org/10.3390/antiox11040627 - DOI - PubMed - PMC
    1. Bolli R (2001) Cardioprotective Function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897–1918. https://doi.org/10.1006/jmcc.2001.1462 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources